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Abstract. Metabolite biosensors are central to current efforts towards precision 
engineering of metabolism. Although most research has focused on building new 
biosensors, their tunability remains poorly understood and is a fundamental aspect for 
their broad applicability. Here we asked how genetic modifications shape the dose-
response curve of biosensors based on metabolite-responsive transcription factors. 
Using the lac system in Escherichia coli as a model system, we built promoter libraries 
with variable operator sites that reveal interdependencies between biosensor dynamic 
range and response threshold. We developed a phenomenological theory to quantify 
such design constraints in biosensors with various architectures and tunable 
parameters. Our theory reveals a maximal achievable dynamic range and exposes 
tunable parameters for orthogonal control of dynamic range and response threshold. 
Our work sheds light on fundamental limits of synthetic biology designs and provides 
quantitative guidelines for biosensor design in applications such as dynamic pathway 
control, strain optimization, and real-time monitoring of metabolism.  
Keywords: metabolite biosensor, dynamic pathway regulation, metabolic engineering, 
transcriptional regulator, pathway optimization, model-based design.
 1 
Introduction 2 
A core principle in synthetic biology is the assembly of biological components into larger systems with 3 
predetermined functions. Metabolite biosensors, in particular, have received substantial attention 4 
because of their role in many applications at the interface of synthetic biology and metabolic 5 
engineering. Biosensors control gene expression in response to small molecules and provide a 6 
powerful tool to probe and control the metabolic state of a host. This makes them versatile for diverse 7 
applications, such as dynamic pathway engineering (1–4), high-throughput screening (5, 6) and 8 
complex genetic-metabolic circuitry (7). 9 
A number of molecular mechanisms have been used for sensing intracellular metabolites, including 10 
e.g. RNA aptamers (8, 9) and metabolite-responsive transcription factors (TFs) (10, 11). The latter 11 
have become particularly popular because many organisms have evolved TFs that respond to native 12 
metabolites. In E. coli, for instance, about a third of TFs are known to respond to metabolites (12). 13 
Metabolite-responsive TFs can be re-purposed as biosensors in a different host (13) or re-engineered 14 
to respond to new ligands (14). The list of compounds for which biosensors have been developed is 15 
growing quickly (11) and includes precursors to biosynthetic pathways as well as products from 16 
secondary metabolism (15–19). 17 
As illustrated in Figure 1A, for the purposes of biosensor design, metabolite-responsive TFs can be 18 
conceptualized as the composition of two modules: a sensing module for the interaction between the 19 
metabolite and the TF, and a regulation module where the TF controls the expression of a target gene. 20 
Biosensors generally have one of four different architectures, depending on the type of interactions of 21 
the sensing and regulation module. Examples of these biosensor architectures can be found across 22 
diverse applications in metabolic engineering, see e.g. the reviews in (10, 11) or Table SF2 in the 23 
Supplementary File S1. 24 
Most applications require biosensors to be tunable, so that designers can adjust biosensor output to 25 
the expected physiological concentration of a metabolite. Common strategies for biosensor tuning 26 
target the sensing and regulation modules separately, either via protein engineering to modify the 27 
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binding kinetics between the metabolite and TF (14, 19), or promoter engineering to modify the 28 
transcriptional activity of the TF (20). Yet a major challenge for biosensor tuning is that their overall 29 
response compounds the effect of sensing and regulation, and thus changes to one component 30 
typically affect all parameters of the dose-response curve simultaneously (Figure 1B). As a result, 31 
biosensor design requires lengthy trial-and-error iterations between genetic modifications and strain 32 
characterization. 33 
Previous studies have focused on the impact of transcriptional processes on the regulatory function of 34 
TFs (21, 22). Such studies have successfully used biophysical models to identify relations between 35 
parameters and the TF dose-response curve (23, 24). In the case of metabolite biosensors, however, 36 
their two-module architecture conflates the effect of metabolite sensing with the regulatory action of 37 
the TF. This makes it difficult to tease apart the impact of tunable parameters on the overall dose-38 
response curve. This is especially relevant in metabolic engineering applications, where biosensors 39 
are typically built with sensing and regulation modules taken from different sources, both of which can 40 
be tuned independently and have diverse molecular mechanisms (10, 11). As a result, biosensor 41 
design can benefit from system-level descriptions that abstract from mechanistic details and highlight 42 
the input-output dependencies among components.  43 
Here we sought to characterize the interdependency between tunable parameters and the dose-44 
response curves of metabolite biosensors. Combining phenomenological modeling and strain 45 
characterization, we provide a simple theory for the design of metabolite biosensors with various 46 
architectures and tunable parameters. Our results highlight fundamental constraints in biosensor 47 
design and expose tunable parameters that facilitate precise control of biosensor function.  48 
 49 
Results and Discussion 50 
Design constraints in dose-response curves of metabolite biosensors 51 
To study the relation between promoter tuning and biosensor function, we focused on metabolite-52 
responsive TFs, the most widespread mechanism employed for sensing small molecules (10, 11, 25). 53 
In these biosensors, a convenient tunable parameter is the affinity of the TF to the promoter operator 54 
site, as it can be modified with rapid and cost-effective techniques such as random mutagenesis of 55 
promoter sequence or changes in operator copy number or location (25, 26).  56 
As a model system for our investigation, we focused on the lactose inducible system in Escherichia 57 
coli. We built eight lacUV5-based promoters with different mutations at the LacI-binding operator site 58 
(sequences in Figure 1C). We incorporated a red fluorescent protein (rfp) gene downstream of each 59 
promoter and measured the dose-response curve to varying concentrations of Isopropyl β-D-1-60 
thiogalactopyranoside (IPTG), a non-metabolizable compound that mimics allolactose and induces 61 
the lac promoter by allosteric binding to the LacI repressor. We characterized the dose-response 62 
curves of each strain though steady state RFP fluorescence in mid-exponential growth. The resulting 63 
dose-response curves display significant differences (Figure 1C), with basal fluorescence outputs 64 
spanning two orders of magnitude and up to two-fold changes in maximal biosensor output. 65 
To quantify the differences among the biosensors, we computed their dose-response parameters as 66 
defined in Figure 1B. We found a strong interdependency between the biosensor parameters for 67 
varying operator sites. In particular, when dynamic range (𝜇) and threshold (𝜃) are plotted against 68 
each other (Figure 1D), we found a fundamental constraint for biosensor design. The constraint 69 
indicates that upon changes in operator affinity, biosensors with a broader dynamic range also display 70 
a larger response threshold. This suggests that tuning the promoter operator site can increase the 71 
dynamic range of the biosensor, but at the cost of simultaneously increasing the level of metabolite 72 
required to elicit a response. 73 
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To explain the observed constraint between threshold and dynamic range, we formulated a general 74 
mathematical model of the biosensors. Motivated by the modular description in Figure 1A, we used 75 
phenomenological models that describe the steady state of the sensing and regulation modules as 76 
Hill functions of their inputs. In the case of the lac system, which corresponds to the repressed-77 
repressor architecture in Figure 1A, the model reads 78 
 𝑓! 𝑀 =  𝑏! +  𝑎!1 + 𝐾!𝑀 !! ,𝑓! 𝑇𝐹 = 𝑏! +  𝑎!1 + 𝐾!𝑇𝐹 !! , 
(1) 
where f1 is the concentration of functional TF that can bind to the operator site as a function of the 79 
metabolite concentration (M), and f2 is the expression level of the target gene (P) as a function of the 80 
concentration of repressor. The parameters ai, bi, Ki, and ni define the shape of the Hill curves for 81 
each module. In particular, the parameters b1 and b2 model the basal level of TF activity and promoter 82 
expression, respectively; parameters a1 and a2 are the maximum increase in TF activity and promoter 83 
expression, relative to their basal levels, respectively; parameter K1 is the metabolite-TF affinity, and 84 
K2 is the TF-operator affinity; and parameters n1 and n2 represent the sensitivity of metabolite-TF and 85 
TF-operator binding, respectively. Although specific molecular mechanisms can be well approximated 86 
by Hill functions similar to Eq. (1) (27–29), in this work we do not instance the models to specific 87 
mechanisms but rather focus on a phenomenological theory applicable to biosensors with various 88 
architectures. The model in Eq. (1) describes the steady state levels of the regulator (TF) and the 89 
target protein (P), and implicitly assumes that mRNA transcripts are also at steady state because 90 
mRNA half-lives are typically much shorter than protein lifetimes (30).  91 
Under the phenomenological model in Eq. (1), the overall response of the biosensor is the composite 92 
function P = f2(f1(M)). The resulting dose-response curve has all the mathematical properties of a 93 
sigmoidal curve, namely, it is monotonically increasing, it has a single inflection point, and it 94 
approaches a finite limit value for large values of M. These properties hold for each of the four 95 
biosensor architectures in Figure 1A (see Supplementary File S1).  96 
From biophysical considerations, it is typically assumed that mutations to the promoter operator site 97 
affect the TF-operator affinity (21, 26). In our phenomenological approach, we further assume that 98 
changes to TF-operator affinity can be captured by perturbations to the K2 parameter only. This 99 
simplification allows us to model each strain in our library with a different value of K2. We numerically 100 
computed the (𝜇,𝜃) parameters from the dose-response curves P = f2(f1(M)) for varying values of K2, 101 
and fitted the model parameters to the (b,𝜇,𝜃) triplets from our fluorescence data (see Methods). 102 
Despite its simplified nature, the results in Figure 1D suggests that our phenomenological model 103 
qualitatively reproduces the observed relation between dynamic range and threshold, thus providing a 104 
simple method to map the impact of mutations to the operator site onto the biosensor dose-response 105 
curve. 106 
Phenomenological theory for biosensor tuning 107 
To further elucidate the constraints that underpin biosensor design, we obtained formulae for the 108 
dose-response parameters in terms of the tunable parameters. For the repressed-repressor 109 
architecture, described by the model in Eq. (1), the dose-response parameters are 110 
 𝑏 = 𝑏! + 𝑎!1 + 𝐾! 𝑏! + 𝑎! !!  , (2) 
 𝑎 = 𝑎! ⋅ 𝑏! + 𝑎! !! − 𝑏!!! ⋅ 𝐾!!!1 + 𝐾! 𝑏! + 𝑎! !! ⋅ 1 + 𝑏!𝐾! !!  , (3) 
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 𝜃 = 1𝐾! ⋅ 𝑎!𝐾!𝐴 − 1!! − 𝑏!𝐾! − 1!!  , (4)  
where A is a function a1, b1, K2, and n2, shown in Supplementary File S1. For brevity, we report the 111 
computation of the biosensor sensitivity in Supplementary File S1.  112 
From Eqs. (2) and (3), we compute the biosensor dynamic range as 113 
 𝜇 = 𝑎𝑏 = 𝜇! ⋅ 𝑏! + 𝑎! !! − 𝑏!!! 𝐾!!!1 + 𝐾! 𝑏! + 𝑎! !! + 𝜇! ⋅ 1 + 𝑏!𝐾! !!  , (5) 
with 𝜇2 = a2/b2 being the dynamic range of promoter expression. The formulae for the dose-response 114 
parameters of the other biosensor architectures (Figure 1A) can be found in the Supplementary File 115 
S1. The results in Eqs. (2)-(5) reveal that the dose-response parameters are coupled to one another 116 
through the TF-operator affinity (K2). Changes to the operator sequence cause simultaneous changes 117 
to the basal output (b), dynamic range (𝜇) and response threshold (𝜃), in accordance with the 118 
dependency observed in our data in Figure 1C.  119 
As shown in Figures 2A for a repressed-repressor architecture, for low TF-operator affinities (K2) the 120 
biosensor produces an almost constitutive, metabolite-independent output, and thus displays low 121 
dynamic ranges. For increases in the K2 parameter, the model predicts a decrease in basal biosensor 122 
output (b), with a relatively minor impact on the maximal output. This causes an increase in dynamic 123 
range and biosensor threshold, in agreement with what we observed in our lac promoter library 124 
(Figure 1D).  125 
For high TF-operator affinities, however, our model predicts that the constraint between dynamic 126 
range and threshold depends strongly on the basal TF activity, modeled by the b1 parameter in Eq. (1). 127 
In the case of the repressed-repressor architecture, the basal TF activity corresponds to the 128 
concentration of TF available for repression at maximum induction. When the b1 parameter is nil, we 129 
found a monotonic relationship between biosensor dynamic range and threshold, but an increased b1 130 
parameter produces a non-monotonic dependency between them (Figure 2B). This constraint 131 
appears in all biosensor architectures (see Supplementary Figure SF1). In the case of the repressed-132 
repressor architecture, this seemingly counterintuitive phenomenon arises because TFs with large 133 
basal activity (high b1) will have some repressors available to bind to the operator site, even at full 134 
induction. Thus, at full induction, an increased TF-operator affinity causes a stronger binding by the 135 
available repressors, decreasing protein expression and lowering biosensor dynamic range (Figure 136 
2B). In contrast, for TFs with negligible basal activity (low b1) we do not observe such a drop in 137 
dynamic range (Figure 2A), because at full induction there are so few repressors available that protein 138 
expression is insensitive to the TF-operator affinity.  139 
A consequence of the constraint in Figure 2B is that changes to the TF-operator affinity can tune the 140 
biosensor threshold within a limited range only. In the case of the repressed-repressor architecture, 141 
the theoretical limits for the biosensor threshold are 142 
 𝜃!"# = 1𝐾! ⋅ 𝜇!2! !!! ⋅ 1 + 1 + 𝜇! !! !!! − 1
!!! ,  (6) 
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𝜃!"# = 1𝐾! ⋅ 𝜇!2 !!! ⋅ 1 + 𝜇! !!1 + 1 + 𝜇! !! !!! − 1
!!! , 
 
(7) 
where 𝜇1 = a1/b1 is the dynamic range of TF activity. The limit thresholds for the other architectures 143 
can be found in Supplementary File S1. From the formula in Eq. (5) we also computed the maximal 144 
dynamic range that is achievable with changes to the TF-operator affinity: 145 
 𝜇!"# = 𝜇! ⋅ 1 + 𝜇! !! − 11 + 𝜇! !!! + 1 + 𝜇! !! ! , (8) 
As shown in Supplementary File S1, the formula for 𝜇max applies to all four biosensor architectures in 146 
Figure 1A. Since Eq. (8) scales with both 𝜇1 and 𝜇2, it suggests that the maximal dynamic range can 147 
be controlled by tuning the TF expression level (through parameter a1) or by adjusting the promoter 148 
strength (through parameter a2). Detailed examination of the formula for 𝜇max, however, reveals that it 149 
has a more pronounced dependency on 𝜇2, which is advantageous because according to Eqs. (2)-(4), 150 
parameter 𝜇1 also affects all the other dose-response parameters simultaneously. 151 
Orthogonal control of dynamic range and threshold 152 
The results in Eqs. (4) and (5) reveal two tunable parameters, promoter dynamic range (𝜇2) and 153 
metabolite-TF affinity (K1), that affect the biosensor dynamic range and threshold separately, whilst all 154 
remaining tunable parameters cause simultaneous changes in both. This means that 𝜇2 and K1 can 155 
be used for orthogonal control of dynamic range and threshold. In particular, the phenomenological 156 
model predicts that 𝜇2 causes a vertical scaling in the (𝜇,𝜃)-curve, while K1 scales it horizontally, as 157 
illustrated in Figure 2C. As shown in Supplementary File S1, we found that this strategy for orthogonal 158 
control is valid in all other biosensor architectures in Figure 1A, thus suggesting a general principle for 159 
biosensor design. 160 
To test the predicted orthogonal control in our lac system, we used two complementary strategies. 161 
First, we induced our strains in Figure 1C with methyl-1-thio-β-d-galactopyranoside (TMG), another 162 
gratuitous lac inducer with an affinity to LacI approximately 10 times lower than IPTG (31), which in 163 
our model corresponds to a reduced K1 parameter. Second, we built six new lac promoters in E. coli. 164 
In addition to mutating the operator sites, the promoter strength was modified by replacing the -35 and 165 
-10 regions of the lacUV5 promoter with those of the sequences from promoter PA1 of phage T7. The 166 
PA1 promoter has a higher binding affinity to RNA polymerase (32), and hence an increased promoter 167 
strength, which in our model corresponds to an increased value for a2 and 𝜇2. 168 
We measured the dose-response curves of both sets of strains with RFP fluorescence, shown in 169 
Figure 3A-B, and quantified the dose-response parameters in Figure 3C. The results show a good 170 
qualitative agreement with our predictions. Strains with increased promoter strength display a larger 171 
dynamic range (Figure 3C, yellow), while a reduced metabolite-TF affinity caused an increase in 172 
response threshold (Figure 3C, blue), both with respect to our original strains in Figure 1C. We re-173 
fitted the mathematical model for both sets of strains and observed that the model produces good fits 174 
in both cases. For the TMG-induced strains (blue curve, Figure 3C), we used the parameters from the 175 
IPTG experiments (Figure 1C) and re-fitted K1 and b1. Although we only expected a change in K1, we 176 
were unable to produce good fits without also re-fitting parameter b1. This is possibly because a lower 177 
affinity decreases the probability of TMG binding, and so at full induction there are fewer repressors 178 
bound to TMG, as compared to those bound to IPTG, resulting in a higher b1. For the strains with a 179 
promoter sequence perturbed at the -35 and -10 regions (yellow curve, Figure 3C), we used the 180 
parameters from the IPTG strains (Figure 1C) and re-fitted a2, b2 and n2. We expected the PA1 181 
promoter sequence to affect parameter a2 only, but we needed to re-fit b2 and n2 as well. This 182 
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suggests biophysical couplings between tunable parameters that are not included in our model. 183 
Nevertheless, the results suggest that biosensor dynamic range increases with the 𝜇2= a2/b2 184 
parameter, with negligible impact on the biosensor threshold, in agreement with our theoretical 185 
prediction.  186 
To verify whether the changes in dynamic range and threshold were indeed orthogonal for changes in 187 
K1 and 𝜇2, we focused on three sets of strains, A1 and A2, B1 and B2, and C1 and C2, shown in Figure 188 
3C. Strains within each set share the same operator sequence, but differ in the sequence of their -35 189 
and -10 promoter regions. This enables us to survey the impact on the response parameters for 190 
changes in the two tunable parameters for each set of strains. A comparison of their response 191 
parameters, shown in Figure 3D, validate the predicted orthogonal control: a decrease in metabolite-192 
TF affinity caused a large change in dose-response threshold and relatively small change in dynamic 193 
range, while a change in promoter strength caused a negligible change in threshold but a large shift in 194 
dynamic ranges. 195 
Discussion 196 
In this work we identified quantitative principles for the design of metabolite biosensors. Previous 197 
research on biosensors has focused primarily on expanding the repertoire of detectable metabolites 198 
(14, 33, 34). Most applications, however, require some degree of tunability on the biosensor dose-199 
response curve, an aspect that remains poorly understood but is fundamental for their broad 200 
applicability. Given the substantial effort required to build new biosensors, a quantitative 201 
understanding of how tunable parameters shape biosensor function can help narrow down the design 202 
space, single out useful architectures, and determine the best experimental strategies to tune them. 203 
Using the lac promoter in E. coli as a model system, we showed that mutations in the operator 204 
sequence simultaneously affect the basal output, dynamic range, and threshold of the dose-response 205 
curve. Such coupling between dose-response parameters makes it challenging to control biosensor 206 
function without a quantitative guideline. We quantified the parameter dependencies with a simple 207 
phenomenological model in which common tunable parameters such as TF-operator affinity, promoter 208 
strength and TF expression level can be readily incorporated, thus providing a widely applicable 209 
theory for biosensor design. Our theory revealed that upon changes in operator affinity, metabolite-210 
responsive TFs are subject to design constraints between dynamic range and response threshold. 211 
These constraints become more severe for ‘leaky’ TFs that have a large basal activity, because they 212 
display a maximal achievable dynamic range that cannot be overcome by changes to the operator 213 
site.  214 
We also found that biosensor dynamic range and threshold can be controlled orthogonally with the 215 
promoter dynamic range and the TF-metabolite binding affinity. Our models predict that this design 216 
principle holds for all considered biosensor architectures. Numerous promoter engineering techniques 217 
can be used to rapidly change promoter properties (20, 35, 36). Although changes to the TF-218 
metabolite binding are significantly more challenging, recent progress in protein engineering have 219 
showcased the construction of metabolite-responsive TFs with perturbed affinities to their cognate 220 
ligands (19, 37), and even modified to bind to new molecules (14, 15). Our results suggest that 221 
promoter libraries with combinatorial designs for operator site and promoter strength cover a large 222 
portion of the design space for the biosensor dynamic range, whilst TF engineering can help to control 223 
the sensing threshold of leaky TFs. 224 
Tunability of biosensors is essential for precision engineering of metabolism. In dynamic pathway 225 
engineering, biosensors control the expression of catalytic enzymes and are core components of 226 
feedback loops that re-route metabolic flux in response to pathway intermediates. For example, tuning 227 
the response curves of acyl-CoA and malonyl-CoA biosensors helped to increase production of fatty 228 
acid and fatty acid-derived fuels in E. coli (1, 2). With adequate tuning of the biosensor dose-response 229 
curve, feedback-regulated pathways can adapt their enzyme levels to the metabolic status of the host, 230 
prevent the accumulation of toxic intermediates, and control pathway variability (3, 4, 16, 38). The 231 
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design constraints we have reported here thus highlight the need for comprehensive characterization 232 
of biosensor libraries. The common approach of tuning biosensors based on dynamic range alone 233 
neglects potential knock-on effects on the sensing threshold, which may render a biosensor 234 
unresponsive to the physiological concentrations of a target metabolite.  235 
Our theory has exposed design constraints applicable to biosensors with any of the four architectures 236 
in Figure 1A. Biosensors with various architectures have been already developed for a number of 237 
applications (10, 11). Our results provide a quantitative framework for controlling dynamic range and 238 
threshold in these biosensors, beyond the repressed-repressor architecture we have studied here. 239 
For example, the activated-activator architecture can be found in biosensors based on the TyrR 240 
regulator (5), while the repressed-activator and activated-repressor architectures can be found in 241 
biosensors based on SoxR and BetI, respectively (19, 39); see Table SF2 in the Supplementary File 242 
S1 for more examples. Furthermore, here we focused on design constraints under a variable operator 243 
affinity, as this is one of the most common tunable parameters. Our theory can be extended to 244 
uncover constraints for other tunable parameters accessible in specific applications, such as variable 245 
promoter strengths (a2 parameter) or promoter sensitivity (n2 parameter), which can be implemented 246 
with promoter libraries with variable RNA polymerase binding sites (36) or operator copy number (2). 247 
We also expect the use of other tunable parameters, such as the TF expression level, to produce 248 
more drastic changes in dose-response curves than those we observed here, for example by affecting 249 
the basal and maximal output simultaneously. 250 
In this work we have deliberately used phenomenological models because they provide a versatile 251 
tool to explore the parameter space for various biosensor architectures. The drawback of this 252 
simplification is that it overlooks the specific mechanisms for metabolite-TF binding and TF regulation 253 
(25). Our models also inherently assume that the tunable parameters are independent from one 254 
another, yet in reality they are coupled through the biophysical interactions between the TF, promoter 255 
and other transcriptional components such as RNA polymerases and 𝜎-factors, which may produce 256 
further design constraints (21, 22). Although our data showed some effects that cannot be fully 257 
explained by our models, overall we found that our phenomenological theory provides a good first 258 
approximation to link design parameters with biosensor dose-response curves. Our approach 259 
revealed constraints in dose-response curves for common tunable parameters, providing a 260 
quantitative basis to identify useful biosensor architectures and to determine suitable experimental 261 
strategies for biosensor tuning.  262 
Unlike most other engineering disciplines, synthetic biology suffers from a limited availability of 263 
sensing devices. Our work has uncovered fundamental design principles for metabolite biosensors, 264 
which in light of the tremendous progress in DNA, RNA and protein engineering, are essential to bring 265 
precision metabolic engineering closer to reality. 266 
 267 
METHODS 268 
Mathematical modeling and curve fitting 269 
The phenomenological models were built through the composite function P = f2(f1(M)), where f1 and f2 270 
are increasing or decreasing Hill functions. The function P(M) is monotonic in M, has a single 271 
inflection point, and reaches its extremal values at M = 0 and M → ∞, thus resembling a sigmoid 272 
function. We obtained the biosensor parameters a and b from the definitions 273 𝑎 = max 𝑓! 𝑓! 𝑀 −min 𝑓! 𝑓! 𝑀  , 𝑏 = min 𝑓! 𝑓! 𝑀  , 
for M ≥ 0, from where the dynamic range is 𝜇 = a/b. We computed the response threshold 𝜃 as the 274 
solution of the equation 275 𝑓! 𝑓! 𝜃 = 𝑏 + 𝑎2, 
which represents the metabolite concentration for 50% output, relative to the basal. The computation 276 
of the dose-response sensitivity is explained in Supplementary File 1. The upper and lower bounds on 277 𝜇 and 𝜃 were computed by differentiation with respect to TF-operator affinity K2 (details in 278 
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Supplementary File S1). Equations (2)-(7) are valid for the repressed-repressor architecture, while Eq. 279 
(8) for the maximal dynamic range is valid for all architectures. Details of the derivation and formulae 280 
of dose-response parameters in all architectures are given in Supplementary File S1.  281 
For the parameter fitting in Figures 1D and 3C, we obtained the dose-response parameters from the 282 
promoter characterization data, 𝜇!,! , 𝜃!,!  and 𝑏!,! , of the ith strain for each of the three sets of 283 
experiments. The dynamic range (𝜇!,!) and basal expression level (𝑏!,!) were calculated from the data 284 
at zero and full induction, and the threshold (𝜃!,!) from fits of a Hill function to the data. The model 285 
predictions (𝜇! , 𝑏! , 𝜃!) were generated from equations (2)-(5) evaluated over a fixed range of K2 from 286 
K2=3×10-5 to K2=103, with the other seven parameters 𝑝 = (𝑎!, 𝑏!,𝐾!, 𝑛!, 𝑎!, 𝑏!, 𝑛!) fitted to the data 287 
triplets (𝜇!,!, 𝜃!,! , 𝑏!,!) via nonlinear least-squares. We solved the optimization problem 288 
 min! 𝜇!,! − 𝜇!,! 𝐾!,! , 𝑝𝜇! ! + 𝜃!,! − 𝜃!,! 𝐾!,! , 𝑝𝜃! ! + log!" 𝑏!,! − log!" 𝑏!,! 𝐾!,! , 𝑝log!" 𝑏! !# Strains!!! , 
where 𝜇!,!, 𝜃!,! and 𝑏!,! are computed from equations (2)-(5) and 𝐾!,! corresponding to the value of 289 𝐾! where the model prediction is closest to the ith data point. Each term of the objective is normalized 290 
by the maximum measured value, denoted 𝜇!, 𝜃! or 𝑏!. In Figure 1D we fitted all model parameters. 291 
The green line is a model fit with parameters reported in Table SF1 in Supplementary File S1. In 292 
Figure 3C (blue) we used the fitted parameters from Figure 1D (green) and re-fitted K1 and b1. In 293 
Figure 3C (yellow), we used the parameters from Figure 1D (green) and refitted a2, b2 and n2. Further 294 
details on the parameter fitting can be found in Supplementary File 1. The parameter fitting was done 295 
through 500 runs of the fmincon solver using the multistart routine from the MATLAB Global 296 
Optimization toolbox. 297 
 298 
Construction and characterization of promoters 299 
The lac promoter libraries were constructed by introducing mutations to the lac operator site in a 300 
Biobrick plasmid pBbB5k-RFP (40). The PA1 promoter library (increased 𝜇2) was cloned by switching 301 
the -35 and -10 regions of the LacUV5 promoter to those of PA1 promoter from phage T7 (sequence 302 
shown in Figure 3B), yielding plasmid pBbB5pgk-RFP. To vary the K2 parameter, two lac promoter 303 
libraries were created with operator sequences AATTGTGANNNGATAACAATT and 304 
AANNNTGAGCGGATAACAAT (Figure 1C, 3A & 3B), generating a strain library with the size of 128 305 
sequences. The lac promoter libraries were constructed using a one-step Golden-Gate DNA 306 
assembly method and were then transformed into MG1655 cells. The promoter libraries were pre-307 
screened from a random selection of colonies from the whole library, and the ones with relatively high 308 
and distinct dynamic ranges were selected for further characterization. 309 
Cell growth and fluorescence were recorded on an Infinite F200PRO (Tecan) plate reader. Strains 310 
were first cultivated overnight in Luria-Bertani (LB) medium supplemented with 50 mg/L kanamycin. 311 
The overnight LB cultures of the lac promoter strains were inoculated 2% v/v into M9 medium 312 
supplemented with 1% glycerol, 50 mg/L kanamycine, and amino acids, composed as for the EZ-rich 313 
medium (41) for adaptation. The overnight culture was inoculated 2% v/v into the same medium and 314 
grew to an OD600 of 0.6. Cell cultures were then diluted by 30-fold in the same medium and induced 315 
with varying IPTG (0.1, 1, 4, 10, 40, 100, 400, and 1000 µM) and TMG (1, 100, 400, 1000, 2000, 4000, 316 
10000, and 40000 µM) concentrations.  317 
Cell density (OD600) and red fluorescence (excitation: 535 ± 9 nm; emission: 620 ± 20 nm) were 318 
recorded every 1000 s until the cell culture reached the stationary phase. Fluorescence from a wild-319 
type E. coli MG1655 cell culture was used as the background, and was subtracted from all 320 
fluorescence measurements. The background-corrected fluorescence was later normalized by cell 321 
density as measured at OD600. Cells were maintained in the exponential growth phase for 5-6 cell 322 
cycles until the normalized fluorescence reached to the steady state, and the steady state 323 
fluorescence were used to generate the dose-response curves. We extracted the biosensor 324 
parameters (b, 𝜇, 𝜃) from Hill functions fitted to the measured dose-response curves. Standard errors 325 
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of the dose-response parameters were calculated from the fitted parameters of the response curves 326 
for biological replicates, for each strain. 327 
SUPPLEMENTARY INFORMATION 328 
- Supplementary Information S1: Mathematical models and analyses in terms of tunable parameters. 329 
- Supplementary Information S2: Promoter characterization data MS Excel format. 330 
AUTHOR CONTRIBUTIONS 331 
A.M. and D.O developed and analyzed the mathematical models. D.L. and F.Z. constructed and 332 
characterized all strains. D.O and F.Z. conceived the project and designed the research. All authors 333 
analyzed data and model predictions. 334 
ACKNOWLEDGEMENTS 335 
This work was funded by the Human Frontier Science Program through a Young Investigator Grant 336 
awarded to D.O and F.Z. (Grant no. RGY0076-2015) and the US National Science Foundation 337 
(MCB1453147) to F.Z. 338 
REFERENCES  339 
1.  Zhang F, Carothers JM, Keasling JD (2012) Design of a dynamic sensor-regulator system for production 340 
of chemicals and fuels derived from fatty acids. Nat Biotechnol 30(4):354–9. 341 
2.  Xu P, Li L, Zhang F, Stephanopoulos G, Koffas M (2014) Improving fatty acids production by engineering 342 
dynamic pathway regulation and metabolic control. Proc Natl Acad Sci 111(31):11299–11304. 343 
3.  Oyarzún DA, Stan G-B V (2013) Synthetic gene circuits for metabolic control: design trade-offs and 344 
constraints. J R Soc Interface 10(78). doi:10.1098/rsif.2012.0671. 345 
4.  Dunlop MJ, Keasling JD, Mukhopadhyay A (2010) A model for improving microbial biofuel production 346 
using a synthetic feedback loop. Syst Synth Biol 4(2):95–104. 347 
5.  Xiao Y, Bowen CH, Liu D, Zhang F (2016) Exploiting nongenetic cell-to-cell variation for enhanced 348 
biosynthesis. Nat Chem Biol 12(5):339–344. 349 
6.  Rogers JK, et al. (2015) Synthetic biosensors for precise gene control and real-time monitoring of 350 
metabolites. Nucleic Acids Res 43(15):7648–7660. 351 
7.  Oyarzún DA, Chaves M (2015) Design of a bistable switch to control cellular uptake. J R Soc Interface 352 
12(20150618). doi:doi: 10.1098/rsif.2015.0618. 353 
8.  Beisel CL, Smolke CD (2009) Design principles for riboswitch function. PLoS Comput Biol 5(4):e1000363. 354 
9.  Berens C, Suess B (2015) Riboswitch engineering - making the all-important second and third steps. 355 
Curr Opin Biotechnol 31:10–15. 356 
10.  Liu D, Evans T, Zhang F (2015) Applications and advances of metabolite biosensors for metabolic 357 
engineering. Metab Eng 31:35–43. 358 
11.  Mahr R, Frunzke J (2016) Transcription factor-based biosensors in biotechnology: current state and 359 
future prospects. Appl Microbiol Biotechnol 100(1):79–90. 360 
12.  Chubukov V, Gerosa L, Kochanowski K, Sauer U (2014) Coordination of microbial metabolism. Nat Rev 361 
Microbiol 12(5):327–40. 362 
13.  Skjoedt ML, et al. (2016) Engineering prokaryotic transcriptional activators as metabolite biosensors in 363 
yeast. Nat Chem Biol 12(11):951–958. 364 
14.  Taylor ND, et al. (2016) Engineering an allosteric transcription factor to respond to new ligands. Nat 365 
Methods 13(2):177–183. 366 
15.  Tang S-Y, Cirino PC (2011) Design and application of a mevalonate-responsive regulatory protein. 367 
Angew Chem Int Ed Engl 50(5):1084–1086. 368 
16.  Liu D, Xiao Y, Evans BS, Zhang F (2015) Negative feedback regulation of fatty acid production based on 369 
a malonyl-CoA sensor-actuator. ACS Synth Biol 4(2):132–140. 370 
17.  Xu P, et al. (2014) Design and Kinetic Analysis of a Hybrid Promoter–Regulator System for Malonyl-CoA 371 
Sensing in Escherichia coli. ACS Chem Biol 9(2):451–458. 372 
18.  Chou HH, Keasling JD (2013) Programming adaptive control to evolve increased metabolite production. 373 
Nat Commun 4:2595. 374 
19.  Saeki K, Tominaga M, Kawai-Noma S, Saito K, Umeno D (2016) The rapid diversification of BetI-based 375 
transcriptional switches for the control of biosynthetic pathways and genetic circuits. ACS Synth Biol. 376 
doi:10.1021/acssynbio.5b00230. 377 
20.  Blazeck J, Alper HS (2013) Promoter engineering: recent advances in controlling transcription at the 378 
most fundamental level. Biotechnol J 8(1):46–58. 379 
21.  von Hippel PH, Berg OG (1986) On the specificity of DNA-protein interactions. Proc Natl Acad Sci U S A 380 
83(6):1608–12. 381 
22.  Bintu L, et al. (2005) Transcriptional regulation by the numbers: Models. Curr Opin Genet Dev 15(2):116–382 
124. 383 
23.  Martins BMC, Swain PS (2011) Trade-Offs and Constraints in Allosteric Sensing. 7(11):1–13. 384 
24.  Ang J, Harris E, Hussey BJ, Kil R, McMillen DR (2013) Tuning response curves for synthetic biology. 385 
ACS Synth Biol 2(10):547–67. 386 
 10 
25.  de Paepe B, Peters G, Coussement P, Maertens J, de Mey M (2016) Tailor-made transcriptional 387 
biosensors for optimizing microbial cell factories. J Ind Microbiol Biotechnol:1–23. 388 
26.  Garcia HG, et al. (2012) Operator sequence alters gene expression independently of transcription factor 389 
occupancy in bacteria. Cell Rep 2(1):150–161. 390 
27.  Yagil G, Yagil E (1971) On the Relation between Effector Concentration and the Rate of Induced Enzyme 391 
Synthesis. Biophys J 11(1):11–27. 392 
28.  Buchler NE, Cross FR (2009) Protein sequestration generates a flexible ultrasensitive response in a 393 
genetic network. Mol Syst Biol 5:272. 394 
29.  Bintu L, et al. (2005) Transcriptional regulation by the numbers: Applications. Curr Opin Genet Dev 395 
15(2):125–135. 396 
30.  Bremer H, Dennis P (1996) Modulation of chemical composition and other parameters of the cell by 397 
growth rate. In Escherichia coli and Salmonella typhimurium. Neidhardt, F (ed) Washington, DC Am Soc 398 
Microbiol Press (122):1553. 399 
31.  Marbach A, Bettenbrock K (2012) lac operon induction in Escherichia coli: Systematic comparison of 400 
IPTG and TMG induction and influence of the transacetylase LacA. J Biotechnol 157(1):82–88. 401 
32.  Lanzer M, Bujard H (1988) Promoters largely determine the efficiency of repressor action. Proc Natl Acad 402 
Sci U S A 85(23):8973–7. 403 
33.  Younger AKD, Dalvie NC, Rottinghaus AG, Leonard JN (2017) Engineering Modular Biosensors to 404 
Confer Metabolite-Responsive Regulation of Transcription. ACS Synth Biol 6(2):311–325. 405 
34.  Nadler DC, Morgan S-A, Flamholz A, Kortright KE, Savage DF (2016) Rapid construction of metabolite 406 
biosensors using domain-insertion profiling. Nat Commun 7:12266. 407 
35.  De Mey M, et al. (2010) Promoter knock-in: a novel rational method for the fine tuning of genes. BMC 408 
Biotechnol 10:26. 409 
36.  Brewster RC, Jones DL, Phillips R (2012) Tuning promoter strength through RNA polymerase binding 410 
site design in Escherichia coli. PLoS Comput Biol 8(12):e1002811. 411 
37.  Richards DH, Meyer S, Wilson CJ (2017) Fourteen Ways to Reroute Cooperative Communication in the 412 
Lactose Repressor: Engineering Regulatory Proteins with Alternate Repressive Functions. ACS Synth 413 
Biol 6(1):6–12. 414 
38.  Oyarzún DA, Lugagne J-B, Stan G-B (2014) Noise propagation in synthetic gene circuits for metabolic 415 
control. ACS Synth Biol. doi:10.1021/sb400126a. 416 
39.  Siedler S, et al. (2014) SoxR as a single-cell biosensor for NADPH-consuming enzymes in Escherichia 417 
coli. ACS Synth Biol 3(1):41–47. 418 
40.  Mason G, et al. (2002) BglBrick vectors and datasheets: A synthetic biology platform for gene expression. 419 
BMC Biotechnol 2(1):20. 420 
41.  Neidhardt FC, Bloch PL, Smith DF (1974) Culture Medium for Enterobacteria. J Bacteriol 119(3):736–747. 421 
  422 
 11 
 423 
FIGURES 424 
 425 
Figure 1. Design constraints in dose-response curves of metabolite biosensors.  426 
(A) General architecture of biosensors based on metabolite-responsive transcription factors (TF). The 427 
metabolite (M) interacts with a TF that controls expression of a target protein (P). The sensing and 428 
regulation modules can be tuned with protein and promoter engineering. (B) Parameters that 429 
characterize a biosensor dose-response curve: basal output (b); response threshold (𝜃), defined as 430 
the amount of metabolite required for 50% output expression relative to the baseline; dynamic range 431 
(𝜇), defined as the maximal increase in expression relative to the basal output; response sensitivity, 432 
defined as the slope of the dose-response curve at the threshold. (C) Dose-response curves of LacI-433 
based biosensors with variable operator sites, in response to IPTG induction. Error bars represent 434 
standard error from biological replicates; some error bars are too small to be observed. (D) Dose-435 
response parameters of the strains in panel C, and fit of the phenomenological model in Eq. (1), 436 
green line. Error bars are the standard error of measured dose-response parameters across biological 437 
replicates; some error bars are too small to be observed. The gray band contains model predictions 438 
for 500 runs of the parameter estimation algorithm; the solid green line is the fit for a specific 439 
parameter set. Further details on the model fitting can be found in Supplementary File 1.  440 
  441 
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Figure 2. Control of biosensor dose-response curves with tunable parameters. 442 
(A) Dose-response curves predicted from the model for biosensors with variable operator affinities. 443 
Our phenomenological theory predicts that tighter TF-operator binding leads to a lower basal output 444 
and a broader dynamic range, accompanied by an increased biosensor threshold. The bottom plot 445 
shows how this coupling between dynamic range (𝜇) and threshold (𝜃) constrains biosensor function, 446 
in agreement with the behavior observed from our data in Figure 1C-D. Parameter values are: a1 = 447 
300, a2 = 1000, b1 = 0.01, b2 = 4.1, n1 = 6, n2 = 2, K1 = 0.1, and K2 values span the range K2 = 0.0005 448 
to K2 = 0.9; all concentrations in 𝜇M. (B) Increased basal TF activity (b1) leads to highly nonlinear 449 
constraints between dynamic range and threshold. Plots show increasing values of the b1 parameter, 450 
from b1 = 0.01 up to b1 = 8. The inset shows the dose-response curves for increasing operator 451 
affinities (K2), at a relatively high basal TF activity (b1 = 8). (C) Two tunable parameters, the promoter 452 
dynamic range (𝜇2) and TF-metabolite affinity (K1), provide orthogonal control and scale the dynamic 453 
range and threshold. Parameter values are the same as in panel A, except a2 = 1700 (yellow curve) 454 
and K1 = 0.04 (blue curve). In all panels, plots shown are for the repressed-repressor architecture, but 455 
the conclusions apply to all biosensor architectures in Figure 1A, see Supplementary File S1.  456 
 457 
 458 
  459 
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Figure 3: Orthogonal control of biosensor dynamic range and threshold.  463 
(A) Dose-response curves of the lac strains from Figure 1C induced with TMG, which has a 10-fold 464 
lower affinity to LacI than IPTG. (B) Dose-response curves of strains with variable operator sites and 465 
increased promoter strength. Error bars represent standard error from biological replicates; some 466 
error bars are too small to be observed. (C) Dose-response parameters and model fits of strains in 467 
panel A (blue curve), and panel B (yellow curve). For comparison, the parameters of the IPTG-468 
induced strains (Figure 1D) are shown here in light gray. Error bars are the standard error of 469 
measured dose-response parameters across biological replicates; some error bars are too small to be 470 
observed. The gray bands contain model predictions for 500 runs of the parameter estimation 471 
algorithm. The solid lines (blue, yellow) are fits for specific parameter sets; the gray band of the blue 472 
curve is too small to be observed. Further details on the model fitting can be found Supplementary 473 
File 1. (D) Validation of the predicted orthogonal control of dynamic range and threshold. We focused 474 
on three sets of strains (Ai, Bi, Ci) that are comparable across the three experiments. Strains within 475 
each set share the same operator sequence, but differ in their -35, -10 promoter region sequence. Bar 476 
plots show the fold change in dose-response parameters for a decreased inducer affinity or increased 477 
promoter strength, with respect to strains in Figure 1D.  478 
 479 
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